|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
|
BACK TO LIST |
TEST PURPOSES ONLY - Enbrel 25 mg powder for solution for injection
Product Details
No product details available
Authorisation Details
| Authorisation number | Region | Marketing authorisation holder |
|---|---|---|
| EU/1/99/126/003 | Pfizer Europe MA EEIG (ORG-100011459) |
B. Package Leaflet
unavailable
Package leaflet: Information for the user
unavailable
What is in this leaflet
unavailable
1. What Enbrel 25 mg powder for solution for injection is and what it is used for
unavailable
2. What you need to know before you take Enbrel 25 mg powder for solution for injection
unavailable
3. How to take Enbrel 25 mg powder for solution for injection
unavailable
4. Possible side effects
unavailable
5. How to store Enbrel 25 mg powder for solution for injection
unavailable
6. Contents of the pack and other information
unavailable
Organizations
| Organization | Type | Information |
|---|---|---|
| Pfizer Europe MA EEIG | Marketing authorisation holder | Boulevard de la Plaine 17,1050 Bruxelles Bruxelles BE |